Countries Europe

Taiwan’s Formosa Pharmaceuticals Partners with Portugal’s DÁVI Farmacêutica to Introduce APP13007 for Post-Surgical Ocular Pain Relief in Europe

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with DÁVI Far...

 November 01, 2024 | News

Siemens Healthineers Expands Atellica Integrated Automation to Atellica CI Analyzer, Transforming Clinical Lab Operations

Siemens Healthineers is pleased to announce the expansion of its Atellica Integrated Automation solution to the Atellica CI Analyzer, bringing advanced aut...

 October 31, 2024 | Product Spotlight

Australia's Telix Pharmaceuticals Partners with Subtle Medical for AI-Powered PET Imaging, Enhancing Illuccix® Efficiency and Patient Experience

Telix Pharmaceuticals announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powere...

 October 31, 2024 | News

Pierre Fabre Doses First Patient with PFL-002/VERT-002, a Novel c-MET Degrader for MET-Altered Cancers

PFL-002/VERT-002 is a monoclonal antibody with a novel and differentiated mechanism of action, acting as a degrader of c-MET, with the potential to be...

 October 25, 2024 | News

Angelini Pharma Secures Global and Asia Licensing Option for Brain Health Compound CV-01 in Partnership with Cureverse

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel...

 October 23, 2024 | News

SGS Launches Pioneering CDISC Open Rules Consultancy to Accelerate Clinical Trial Submissions

SGS, the world’s leading testing, inspection and certification company, has today launched its pioneering ‘CDISC Open Rules Consultancy’,...

 October 23, 2024 | News

Recursion Doses First Patient in Phase 2 Trial of REC-3964, a Novel Non-Antibiotic Treatment for Recurrent C. difficile Infection

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a uni...

 October 23, 2024 | News

Sanofi and CD&R Join Forces to Accelerate Opella’s Growth in Consumer Healthcare

Sanofi and Clayton, Dubilier & Rice (CD&R) announced exclusive negotiations for the transfer of a 50% controlling stake in Opella, Sanofi's consume...

 October 22, 2024 | News

CSL Vifor and Travere Therapeutics Secure Swissmedic Approval for FILSPARI in Treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics, announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the treatment of adults w...

 October 18, 2024 | News

Isolere Bio by Donaldson Introduces Research-Grade IsoTag™ AAV Reagent for Superior Viral Vector Purification

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of research-grade IsoTag™ AAV reagent, ...

 October 18, 2024 | News

BD and Hamilton Collaborate to Streamline Genomic Sequencing with Automation-Ready Reagent Kits

Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing  &nb...

 October 15, 2024 | News

Thermo Fisher Introduces Iliad (S)TEM: Advancing Atomic-Level Insights with EELS and NanoPulser Technology

Thermo Scientific Iliad integrates electron energy loss spectroscopy (EELS) and NanoPulser electrostatic beam blanker to improve insights at the atomic lev...

 October 15, 2024 | News

Leading Drug Discovery CRO NovAliX Partners with Bruker to Transform Therapeutic Innovation

Bruker Acquires Minority Stake in NovAliX in Strategic Move Partnership Leverages Synergies Between Premium Drug Discovery CRO and High-Value Life Scien...

 October 11, 2024 | News

Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio

Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development  Av...

 October 11, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close